Good announcement! MLA has made its first move after shedding...

Good announcement! MLA has made its first move after shedding the Medivet millstone. The whole area of infections in hospitals seems to be a tremendous opportunity. This subject gets a lot of play in the US where the rate if infection is a bit higher and the community has a much higher awareness. Late last year I saw some articles in the press talking about the major health insurers refusing to reimburse hospitals in Sydney for complications that were attributable to a patients stay in hospital where they had contracted golden staph. The costs of these infections should more than justify the extra cost of buying the DualCap product but more importantly 7,000 deaths a year should force hospitals to introduce this product.  If it were your mother, father, child etc, you would want to know that the hospital was taking every opportunity to protect them. Have a closer look yourself at www.dualcap.com.
I look forward to more developments from MLA in this area.